Gene: HIF1A
Official Full Name: hypoxia inducible factor 1 subunit alphaprovided by HGNC
Gene Summary: This gene encodes the alpha subunit of transcription factor hypoxia-inducible factor-1 (HIF-1), which is a heterodimer composed of an alpha and a beta subunit. HIF-1 functions as a master regulator of cellular and systemic homeostatic response to hypoxia by activating transcription of many genes, including those involved in energy metabolism, angiogenesis, apoptosis, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF-1 thus plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00243 | Hif1a gRNA5-gRNA6 KO plasmid | Hif1a | $850 | |||
GP00270 | Hif1a gRNA1-gRNA2 KO plasmid | Hif1a | $850 | |||
KO01152 | Hif1a Knockout cell line (Hepa 1-6) | Mouse | Hif1a | 1:2~1:4 | Negative | Online Inquiry |
KO01200 | Hif1a Knockout cell line (RAW 264.7) | Mouse | Hif1a | 1:2-1:3 | Negative | Online Inquiry |
HIF1A Gene Knockout Cell Lines are engineered cellular models that lack functional hypoxia-inducible factor 1 alpha (HIF1A), a key transcription factor that regulates cellular response to hypoxia. These knockout cell lines are crucial for studying the molecular mechanisms underpinning oxygen sensing and adaptation in various physiological and pathological contexts. The primary function of HIF1A involves activating a plethora of genes that facilitate metabolic adaptation to low oxygen conditions, influencing processes such as angiogenesis, metabolism, and cell survival.
In research and clinical settings, HIF1A knockouts serve as invaluable tools for understanding cancer biology, metabolic diseases, and ischemic conditions. By elucidating the role of HIF1A in these processes, scientists can identify potential therapeutic targets and mechanisms of drug resistance. For instance, the study of HIF1A-deficient cell lines enables researchers to explore how tumor cells adapt to hypoxic environments, providing insights into tumor progression and metastasis.
One major advantage of using HIF1A Gene Knockout Cell Lines lies in their specificity and high-fidelity gene editing, which allows for precise targeting of the HIF1A gene without off-target effects commonly associated with other gene editing techniques. Moreover, these cell lines can be adapted for high-throughput screening applications, making them suitable for drug discovery and toxicology studies.
For researchers and clinicians aiming to deepen their understanding of hypoxia-related pathways, HIF1A Gene Knockout Cell Lines present a unique opportunity. By providing a stable and reproducible model system, they enable rigorous experimentation and facilitate the translation of laboratory findings into therapeutic strategies.
At [Company Name], we specialize in the development and production of advanced biological products, including customized gene knockout models, thereby ensuring a commitment to quality and innovation tailored to the diverse needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.